Search research articles
Contact Us
Filters
Showing results (421-430 of 430) with videos related to
Page
of 43
Sort By:
You have reached the last page of results.
This site can display upto 430 results.
Diagnostics (Basel, Switzerland)
|
December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network
Richard Colling, Andrew Protheroe, Mark Sullivan, et al.
Nature Communications
|
December 31, 2025
Phosphoproteomics of aged insulin-resistant bone identifies P70S6K phosphorylation of AFF4 as a gene-specific transcriptional regulator
Mriga Dutt, Luoping Liao, Hani Jieun Kim, et al.
Science Translational Medicine
|
February 8, 2019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
Matthew J Watt, Ashlee K Clark, Luke A Selth, et al.
Iscience
|
July 8, 2024
Pleiotropic brain function of whirlin identified by a novel mutation
Carlos Aguilar, Debbie Williams, Ramakrishna Kurapati, et al.
Nature Genetics
|
October 5, 2001
A radiation hybrid map of mouse genes
T J Hudson, D M Church, S Greenaway, et al.
Cell Metabolism
|
July 26, 2022
Phosphoproteomics of three exercise modalities identifies canonical signaling and C18ORF25 as an AMPK substrate regulating skeletal muscle function
Ronnie Blazev, Christian S Carl, Yaan-Kit Ng, et al.
European Heart Journal
|
December 15, 2021
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
, , E Sammons, et al.
Nature Genetics
|
August 4, 1999
A YAC-based physical map of the mouse genome
C Nusbaum, D K Slonim, K L Harris, et al.
NPJ Breast Cancer
|
December 2, 2021
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi, Harry R Haynes, Elizabeth Blackley, et al.
The Journal of Pathology
|
March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Page
of 43
Search research articles
Search
Showing results (421-430 of 430) with videos related to
Sort By:
Page
of 43
You have reached the last page of results.
This site can display upto 430 results.
Diagnostics (Basel, Switzerland)
|
December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network
Richard Colling, Andrew Protheroe, Mark Sullivan, et al.
Nature Communications
|
December 31, 2025
Phosphoproteomics of aged insulin-resistant bone identifies P70S6K phosphorylation of AFF4 as a gene-specific transcriptional regulator
Mriga Dutt, Luoping Liao, Hani Jieun Kim, et al.
Science Translational Medicine
|
February 8, 2019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
Matthew J Watt, Ashlee K Clark, Luke A Selth, et al.
Iscience
|
July 8, 2024
Pleiotropic brain function of whirlin identified by a novel mutation
Carlos Aguilar, Debbie Williams, Ramakrishna Kurapati, et al.
Nature Genetics
|
October 5, 2001
A radiation hybrid map of mouse genes
T J Hudson, D M Church, S Greenaway, et al.
Cell Metabolism
|
July 26, 2022
Phosphoproteomics of three exercise modalities identifies canonical signaling and C18ORF25 as an AMPK substrate regulating skeletal muscle function
Ronnie Blazev, Christian S Carl, Yaan-Kit Ng, et al.
European Heart Journal
|
December 15, 2021
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
, , E Sammons, et al.
Nature Genetics
|
August 4, 1999
A YAC-based physical map of the mouse genome
C Nusbaum, D K Slonim, K L Harris, et al.
NPJ Breast Cancer
|
December 2, 2021
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi, Harry R Haynes, Elizabeth Blackley, et al.
The Journal of Pathology
|
March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Page
of 43